Docetaxel albumin-bound for advanced pancreatic cancer
Treatments studied
Part of Cancer clinical trials.
This trial tests a new form of docetaxel (a chemo drug) given as an injection for people with advanced pancreatic cancer who have already tried standard treatments. It aims to see if this drug can shrink tumors or slow disease progression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have advanced pancreatic cancer (including a type called adenosquamous carcinoma).
- Your cancer must have progressed or you must have had serious side effects after at least one prior standard treatment (like gemcitabine or fluorouracil).
- You need to be at least 18 years old and generally able to care for yourself (ECOG score 0-2).
- Blood counts, liver and kidney function must be within a certain range (your doctor will check this).
- You cannot have serious heart problems, uncontrolled infections, or recent major surgery that hasn't healed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called LM-108 combined with chemotherapy for people with advanced pancreatic cancer that hasn't been treated before. The goal is to see if it's safe and may help shrink tumors or stop them from growing.
This study tests a new treatment approach for advanced pancreatic cancer in patients who have never received chemotherapy for their advanced disease. The trial aims to evaluate whether this new strategy can help control the cancer and improve outcomes.
This trial studies a chemotherapy combination (albumin-bound paclitaxel and gemcitabine) as first treatment for pancreatic cancer that cannot be removed by surgery. It aims to improve outcomes by testing how well this treatment works in people with locally advanced or metastatic disease.
This trial is testing a new form of the chemotherapy drug docetaxel (called albumin-bound docetaxel) for people with advanced stomach or gastroesophageal junction cancer that has worsened after initial treatment. It aims to see if this version of the drug works better or has fewer side effects.
This trial tests a new form of the chemotherapy drug paclitaxel (called polymeric micellar paclitaxel) for people with pancreatic cancer that has spread to other parts of the body (metastatic). It's for those who haven't had any prior treatment for their metastatic cancer, and aims to see if this drug can help control the cancer.
This trial tests a new drug called IBI343 combined with standard chemotherapy for people with advanced pancreatic cancer that cannot be removed by surgery. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
Hear when a new Advanced Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.